Staphylococcus aureus is a dangerous human pathogen whose antibiotic resistance is steadily increasing and no efficient vaccine is as yet available. This serious threat drives extensive studies on staphylococcal physiology and pathogenicity pathways, especially virulence factors. Spl (serine protease-like) proteins encoded by an operon containing up to six genes are a good example of poorly characterized secreted proteins probably involved in virulence. In the present study, we describe an efficient heterologous expression system for SplA and detailed biochemical and structural characterization of the recombinant SplA protease. The enzyme shares a significant sequence homology to V8 protease and epidermolytic toxins which are well documented staphylococcal virulence factors. SplA has a very narrow substrate specificity apparently imposed by the precise recognition of three amino acid residues positioned N-terminal to the hydrolysed peptide bond. To explain determinants of this extended specificity we resolve the crystal structure of SplA and define the consensus model of substrate binding. Furthermore we demonstrate that artificial N-terminal elongation of mature SplA mimicking a naturally present signal peptide abolishes enzymatic activity. The probable physiological role of the process is discussed. Of interest, even though precise N-terminal trimming is a common regulatory mechanism among S1 family enzymes, the crystal structure of SplA reveals novel significantly different mechanistic details.
INTRODUCTION
Species of the Staphylococcus genus are commensal inhabitants of man and warm-blooded animal epithelium [1] . Nearly 30 % of the human population is persistently colonized by Staphylococcus aureus without visible adverse effects. At the same time the bacterium is a dangerous opportunistic pathogen. Microinjuries of skin or surgical wounds can lead to invasion of subepithelial tissues. S. aureus reveals a great ability to overcome host defence mechanisms and colonize diverse organs. The pathogen is equipped with a number of secreted factors facilitating superficial and systemic infections. Examples of soft tissue superficial infections include impetigo, folliculitis, abscesses, boils or infected lacerations [2] . Deep systemic infections are more dangerous and often life-threatening (e.g. endocarditis, meningitis, septic arthritis, pneumonia or osteomyelitis) [3] . The most serious outcome of S. aureus infection is septicaemia. Moreover, the bacterium is responsible for several toxinoses, such as SSSS (staphylococcal scalded skin syndrome), TSS (toxic shock syndrome) and food poisoning. The wide variety and severity of infections caused by S. aureus together with a frightening increase in multi-antibiotic resistance and the lack of effective vaccines poses an urgent need for novel therapeutic strategies [4, 5] . This in turn necessitates deeper understanding of staphylococcal physiology and pathogenicity pathways.
Virulence factors responsible for staphylococcal pathogenicity encompass secreted toxins, immune-modulatory and adhesion molecules, signalling factors and extracellular enzymes, including a number of proteases [6] . The role of cysteine proteases staphopain A and B, metalloprotease aureolysin, serine protease V8 (glutamylendopeptidase) and epidermolytic toxins in staphylococcal virulence is documented in multiple reports [7] [8] [9] [10] . Furthermore, screening of a library of staphylococcal proteins with antisera from patients with S. aureus endocarditis clearly showed that a new serine protease-like protein, SplC, is expressed during infection [11] . Follow-up investigations demonstrated that SplC is a product of a gene belonging to an operon encoding up to six homologous Spl proteases in various strains of S. aureus [12] . Despite their suggested involvement in pathogenesis, the Spl proteases remain poorly characterized. Similar to other staphylococcal exo-proteins, in vitro the spl operon is transcribed during early stationary phase of bacterial growth [13] . It is postulated that similar regulation operates in vivo and is essential for dissemination of the pathogen from initial colonization sites. Therefore, Spl proteases together with multiple similarly regulated documented virulence factors may play a role in the second invasive stage of the infection. The probable contribution of Spl proteases to S. aureus pathogenicity is further substantiated by structural similarities to established virulence factors, such as V8 protease and epidermolytic toxins, and clustering of the spl genes on a stable pathogenicity island (vSaβ) [14, 15] .
To date, out of six Spl proteins only SplB and SplC have been studied in some detail. The lack of proteolytic activity of SplC was explained on the atomic level by showing that the catalytic machinery is significantly distorted in the crystal structure of the protein. Moreover, crystal structure of the highly specific protease SplB shows a lack of an important element of serine-protease catalytic machinery, the oxyanion hole. By comparison with epidermolytic toxins, the authors speculated that binding of an appropriate substrate could induce activating changes in SplC, similarly to SplB, whose activity seems to be induced by binding of a substrate encompassing the sequence Trp-Glu-LeuGln [15, 16] .
In the present study, to cast more light on the staphylococcal proteases of spl operon, we have produced SplA using heterologous expression system in Bacillus subtilis and performed biochemical and structural characterization of the recombinant protein. We demonstrate a crucial effect of proper N-terminal trimming for SplA activity. Of interest, we characterize the strict specificity of the enzyme imposed by recognition of amino acid residues at the P1, P2 and P3 positions of the substrate (nomenclature according to Schechter and Berger [17] ). The structural basis of substrate preference and significance of the Nterminal residue of the mature protein in SplA activity are visualized at the atomic level and contrasted with typical proteases of the chymotrypsin family.
EXPERIMENTAL Bacterial strains, plasmids, protein expression and purification
Escherichia coli strains DH5α and BL21(DE3) (Invitrogen) were used for genetic manipulations and protein expression respectively. For production of GST (glutathione transferase)-GS-SplA (GS indicates that following tag removal, a Gly-Ser artifact remains at the N-terminus of SplA compared with the native protein), the splA gene (without a signal peptide) was PCR amplified from the genomic DNA of S. aureus strain 8325-4 and cloned into BamHI/XhoI sites of pGEX-5T [18] . GST-YLYS-Staphostatin A fusion protein (GST-YLYS-ScpB; YLYS indicates a Tyr-Leu-Tyr-Ser sequence engineered between two globular fusion partners) was produced as previously described in [19] with the exception that in the middle part of the construct the amino acid sequence recognized by thrombin (LVPRGS) was exchanged by site-directed mutagenesis into a consensus amino acid sequence recognized by SplA (LVYLYS). For SplA production, the B. subtilis strain WB800 carrying a pWB980 vector [20] with the splA gene (without a native signal peptide) inserted at HindIII/XhoI sites was used.
E. coli cells containing the pGEX5T-GS-SplA vector were cultured at 37
• C in LB (Luria-Bertani) broth containing ampicillin (100 μg/ml) until D 600 reached 0.8 attenuance units and then at room temperature (20 • C ). Protein expression was induced with 1 mM IPTG (isopropyl β-D-thiogalactoside) when the cultures reached D 600 of 1.2 attenuance units. After 3 h, cells were collected in PBS and lysed by sonication. A protein of interest was recovered using glutathione-Sepharose (Amersham Biosciences). The GST fusion tag was removed using thrombin (BioCentrum). GS-SplA was further purified by ionexchange chromatography (SoruceS; Amersham Biosciences; 50 mM sodium acetate, pH 6.5) followed by gel filtration on Superdex 75pg (Amersham Biosciences) equilibrated with PBS.
Routinely recombinant SplA was produced in B. subtilis WB800 carrying pWB980-SplA plasmid driving a constitutive secretory expression. The cells were cultured at 37
• C overnight in TSB (tryptic soy broth; Sigma) medium containing kanamycin (10 μg/ml). Cell-free supernatants were collected by centrifugation (20 min; 4 • C; 5000 g) and proteins were precipitated with ammonium sulfate at 80 % saturation at 4
• C (561 g/l). Precipitated proteins were collected by centrifugation, resuspended in buffer A (50 mM ammonium acetate, pH 5.5) and dialysed overnight against the same buffer. SplA was recovered by ion-exchange chromatography on SP-Sepharose Fast Flow (Amersham Biosciences) equilibrated with buffer A. Fractions with conductivity between 27 mS/cm and 37 mS/cm, containing proteolytic activity, were collected, and rechromatographed on SourceS (Amersham Biosciences) in buffer B (50 mM ammonium acetate, pH 5.0). Proteolytically active fractions were collected and further purified on Superdex 75pg (Amersham Biosciences) equilibrated with crystallization buffer (5 mM Tris and 50 mM NaCl, pH 8.0).
GST-YLYS-ScpB was purified as previously described for GST-ScpB [19] .
Proteolytic activity assays
Activity of SplA was routinely tested by casein zymography [21] . Briefly, samples were incubated with SDS loading buffer (without reducing agent) in 37
• C for 30 min and separated on 12 % (w/v) polyacrylamide gel containing 0.1 % β-casein. Following electrophoresis, the gel was washed for 30 min in 2.5 % (v/v) Triton X-100 and developed for 3 h or overnight in 100 mM Tris (pH 7.8), 100 mM NaCl and 5 mM EDTA at 37
• C. Zones of proteolysis were visualized by staining with Amido Black.
Synthetic chromogenic substrates tested included: H-AFpNa (alanyl-phenylalanine-p-nitroanilide), H-GF-pNa (glycylphenylalanine-p-nitroanilide), N-Suc-F-pNa (N-succinyl-phenylalanine-p-nitroanilide), N-Suc-AAPF-pNa (N-succinyl-alanylalanyl-prolyl-phenylalanine-p-nitroanilide), N-Ac-LY-pNa (Nacetyl-leucyl-tyrosine-p-nitroanilide), N-Suc-LF-pNa (N-acetylleucyl-phenylanaline-p-nitroanilide) and N-Suc-AAA-pNa (Nsuccinyl-alanyl-alanyl-alanine-p-nitroanilide). SplA (20 μg) was incubated with 0.5 mM substrate in a total volume of 200 μl 100 mM Tris/HCl, pH 7.0 for 16 h at 37
• C in a microtitration plate. Following incubation, absorbance at 405 nm was measured using a plate reader. The pH optimum of SplA was determined using N-Suc-AAPF-pNa. This substrate was also used to assay the effect of synthetic serine protease inhibitors, including PMSF, AEBSF [4-(2-aminoethyl)benzenesulfonyl fluoride] and DCI (3,4-dichloroisocoumarin) on SplA activity.
A number of native proteins and peptides, including chicken egg white lysozyme and ovalbumin, soyabean trypsin inhibitor, human serum transferrin, BSA, RNAse, cytochrome c, β-casein, galanine, goat IgGs, bovine and human fibrinogen and whale myoglobin were tested for hydrolysis by SplA in 100 mM BisTris buffer (pH 6.5). Moreover, proteins denatured by chemical modification, including carboxymethylated chicken egg white lysozyme and BPTI (bovine pancreatic trypsin inhibitor), as well as apomyoglobin and apocytochrome c were evaluated as substrates for SplA.
Human serum serine protease inhibitors, including α 1 -antitrypsin, α 1 -antichymotrypsin, antithrombin and α 2 -macroglobulin were tested for inhibition of SplA activity. The residual activity was determined using GST-YLYS-ScpB as a substrate after 30 min preincubation of SplA with a tested inhibitor at 1:100 molar ratio. In addition, SplA-inhibitor reaction mixtures after 15 min of incubation at 37
• C were analysed by SDS/PAGE for inhibitory complex formation or potential inhibitor cleavage.
Edman degradation and MALDI-TOF (matrix-assisted laser-desorption ionization-time-of-flight) MS analysis
For N-terminal sequence determination, protein cleavage products were separated by SDS/PAGE, electroblotted on PVDF and sequenced by automated Edman degradation sequencing at BioCentrum.
For determination of molecular masses the protein cleavage products were separated by HPLC and subjected to MALDI-TOF MS analysis.
Positional scanning substrate libraries
To assess the preference of SplA for amino acid residues at the P1 substrate position, positional scanning substrate libraries were used as described previously [22] .
CLiPS (cellular library of peptide substrates)
A complete consensus sequence recognized and cleaved by SplA protease was discerned using a CLiPS methodology as previously described [23] . Briefly, a library of 6 × 10 7 clones displaying a bait polypeptide containing an SH3 (Src homology 3) domain-binding motif, a linker consisting of five consecutive randomized amino acids and a streptavidin-binding peptide ligand was screened for proper display and SplA hydrolysis using FACS. Clones with intact baits show red and green fluorescence after incubation with phycoerythrin-conjugated streptavidin (50 nM) and SH3 domainconjugated GFP (green fluorescent protein; 250 nM). Clones displaying substrates that were specifically hydrolysed after 16 h of incubation with 0.5 μM SplA were obtained by sorting the green-fluorescing cells only. After three rounds of sorting, individual clones were analysed for hydrolysis by incubating with 0.5 μM SplA for 3 h, and clones demonstrating hydrolysis were sequenced (Table 1) .
Protein crystallization and structure solution
Purified active SplA, and SplA that had undergone reaction with phosphonate inhibitor [24, 25] were concentrated by ultrafiltration to ∼ 30 mg/ml in crystallization buffer and used for initial screening. After a few weeks, crystals appeared in several different conditions. For active SplA, following further optimization a best single monocrystal of approx. 0.3 mm length was obtained using Hampton Research Index 23 (2.1 M DL-malic acid, pH 7.0) and was used for measurements. The crystal was mounted in a glass capillary and the diffraction data were collected on a rotating anode laboratory source at room temperature. The best single monocrystal of inhibited SplA obtained from an in-house screen [0.1 M Hepes, pH 7.5, 0.2 M (NH 4 ) 2 SO 4 and 30 % poly(ethylene glycol) 6000] [26] was cryo-preserved in liquid nitrogen. The diffraction data were collected at SLS beamline X10SA.
Data were indexed and integrated using MOSFLM [27, 28] . Computational steps were performed using programs contained in the CCP4 package [29] . The data were scaled in SCALA [30, 31] . Molecular replacement solution was found using Phaser [32] with SplC (PDB ID 2as9) as a search model. The SplA model was manually built in the resulting electron density maps. Restrained refinement of bond lengths and angles was imposed with Refmac 5.0 [33] . Throughout the refinement 5 % of the reflections were used for cross-validation analysis [34] , and the behavior of R free was employed to monitor the refinement strategy. Water molecules were added using Arp/Warp [35] and subsequently manually inspected. All detailed features described in the text were validated using simulated annealing omit maps computed with CNS [36, 37] . The final models were deposited in the PDB under accession numbers 2w7u and 2w7s. The data collection and refinement statistics are summarized in Table 2 .
Homology modelling
ϕ and ψ main-chain angles of a substrate were modelled as found in canonical inhibitors of serine proteases, which bind in a manner resembling natural substrates [38] . The substratebinding surface of SplA was identified based on homology to S1 family proteases. The substrate model was manually docked into the substrate-binding surface of the enzyme. Minor corrections of the main-chain disposition within the template derived from canonical inhibitors were performed to optimize recognized hydrogen bonds [39] . The side chains were added according to the identified consensus sequence recognized by SplA. Side-chain disposition was modelled based on structures of S1 family proteases complexed with synthetic and protein inhibitors. Following this, hydrogen atoms were added to the model using the AddH module of the UCSF Chimera package [40] , potentials were assigned according to Amber 1994 force field [41] and the energy of the complex was minimized using MMTK module of Chimera with default values [42] . Manual structure edition, structure analysis and molecular graphics were done using modules of Chimera and spdbv (Swiss PDB viewer).
Bioinformatic analysis
Human (Homo sapiens, taxid: 9606) and staphylococcal (S. aureus, taxid:1280) proteomes were analysed for potential cleavage sites with the deduced consensus sequence recognized by SplA (YLYS) using BLAST algorithm and Uniprot database. Initial hits were manually examined to remove redundant sequences. The remaining proteins were analysed for tissue and cellular localization (for a list of all non-redundant hits see Supplementary  Table S1 at http://www.BiochemJ.org/bj/419/bj4190555add.htm) to pinpoint those directly spatially colocalized with staphylococci during commensal colonization and/or infection.
RESULTS

Production of recombinant SplA
Initially SplA was expressed as a GST fusion protein in E. coli and the tag was cleaved off with thrombin during the purification procedure. This produced recombinant GS-SplA that was inactive in zymographic assays using gelatin and β-casein as substrates. As was the case with related protease SplB [15, 16] , the lack of the proteolytic activity could have been related to the presence of a Gly-Ser dipeptide, a remnant of the thrombin cleavage site, on the N-terminus of GS-SplA. To investigate this option, recombinant SplA was directed on to the secretory pathway to ensure proper N-terminal trimming by signal peptidase. B. subtilis expression plasmid pWB980, driving constitutive production and secretion of SplA, was constructed and transformed into a knockout strain WB800 lacking the majority of endogenous extracellular proteases. Obtained in this way, the recombinant SplA showed proteolytic activity in zymography, indicating the importance of the N-terminus for enzymatic activity. The system yielded approx. 5 mg of purified protein per 1 litre of a starting culture. Thus produced protein was used in all further analyses.
Substrate specificity of SplA
To characterize SplA activity, we have evaluated an array of synthetic p-nitroanilide substrates. Among the tested compounds (see the Experimental section), only N-Suc-Ala-Ala-Pro-Phe-pNa was hydrolysed, although very inefficiently. Nevertheless, using this substrate, we estimated the pH optimum of the protease at pH 6.5 (Bis-Tris buffer). Moreover, we have demonstrated that, amongst the common low-molecular-mass serine protease inhibitors tested, only DCI inhibited SplA.
The P1 substrate preference of SplA was determined by screening the enzyme activity against a panel of combinatorial libraries of synthetic fluorescent substrates with a general structure of Ac-Xaa-Xaa-Xaa-P1-AMC (where AMC is amino-4-methylcoumarin). SplA exclusively hydrolysed substrates with monocyclic aromatic residues in P1, namely tyrosine and to a lesser extent phenylalanine (Figure 1 ). The substrate specificity was further evaluated using MS and N-terminal microsequencing analysis of cleavage products of β-casein and carboxymethylated chicken lysozyme. The results confirmed SplA preference for phenylalanine and tyrosine in P1 ( Table 1 ). The cleavage kinetics of casein and lysozyme was, however, extremely slow, requiring an excess of an enzyme and prolonged incubation times. Significantly, none of the other tested native and denatured protein substrates or human serum serine protease inhibitors (for the complete list, see the Experimental section), all containing multiple phenylalanine and tyrosine residues, were cleaved by SplA. The above results collectively suggest that SplA specificity is determined not only in P1, but also in further subsites.
To determine the preference of SplA for particular residues in P(n) as well as P(n) positions and to account for possible subsite co-operation, we have applied a high-throughput CLiPS methodology [23] . A library presenting five consecutive randomized amino acids in the context of a cell surface protein was selected for SplA cleavage. The analysis demonstrated that SplA recognizes and cleaves a consensus sequence of four consecutive residues Trp/Tyr-Leu-Tyr-Thr/Ser (Table 1) .
Taking into account the P1 preference for monocyclic aromatic residues, there are two possible cleavage sites in the consensus sequence. To determine which peptide bond is hydrolysed and demonstrate that SplA can efficiently cleave proteins containing this sequential motif, we have constructed a fusion protein of two globular partners with a linker containing the identified consensus amino acid sequence (YLYS). At a 1:100 enzyme/substrate molar ratio, 160 μg of purified fusion protein (GST-YLYS-ScpB) was completely and specifically split into free GST and ScpB in 15 min (Supplementary Figure S1 
at http://www.BiochemJ.org/bj/419/bj4190555add.htm). Edman degradation sequencing of the released N-terminus revealed hydrolysis of the Tyr-Ser peptide bond within the consensus sequence.
Collectively, these data demonstrate that SplA is a highly selective protease that can cleave efficiently only substrates containing the Trp/Tyr-Leu-Tyr-Thr/Ser sequence motif.
Overall crystal structure of SplA protease
To explain the narrow specificity of SplA at the atomic level we have crystallized and solved the enzyme structure. Two independently determined structures are discussed (Table 2) , a 2.43 Å (1 Å = 0.1 nm) structure of an active SplA protease, 2w7u, and 1.8 Å structure of a Sp1A protease reacted with phosphonate inhibitor, 2w7s. Both structures are essentially identical (the average RMSD [RMS (root mean square) deviation] of backbone atoms for all eight models equals 0.45) since the inhibitor has hydrolysed during crystallization and is not accounted for by electron density. Therefore, the low resolution model is discussed mainly to demonstrate said identity, the importance of which is stressed in the Discussion. Unless otherwise indicated, the 1.8 Å structure is used to discuss the structural details.
The protein shows a chymotrypsin-like fold. The SplA molecule consists of two domains (I and II), each of which is built of six anti-parallel β-strands folded into a β-barrel (Figure 2 46 form a helix in models A and B, which protrudes with its C-terminal part away from the globular core of the molecule. In models C and D, residues 42-47 and 42-43 respectively are not defined by electron density. The average B factors for residues 38-49 are higher than that of surrounding residues. In all models the entire discussed region forms close contacts with surrounding molecules. Of note, on top of the protrusion the hydrophobic side chain of Phe 47 is buried in a shallow pocket of the adjacent molecule.
Primary sequence analysis shows significant homology between SplA and other chymotrypsin-like serine proteases from S. aureus (38 % with V8 protease and 27 % with the epidermolytic toxins ETA and ETB). Accordingly, the superimposition of the Cα atoms of SplA and V8 protease yields an RMSD of 1.0 Å (over 165 Cα atoms) and with epidermolytic toxins A and B of 1.1 Å (153 Cα atoms) and 1.1 Å (146 Cα atoms) respectively.
Catalytic triad
The conformational restraints of the catalytic triad, an essential element of the catalytic machinery of S1 family serine proteases, are not satisfied in the structure of SplA. Sequence alignment and superposition of V8 protease, SplB and SplA models demonstrate the presence of the three essential residues (His 39 , Asp 78 and Ser 154 in SplA); nevertheless, the crucial hydrogen bonding network between the side-chains of those residues is not present in the SplA structure (Figure 3 is not directly involved in intermolecular contacts (besides His39_B of the 2.43 Å structure). The described unusual arrangement of catalytic triad histidine is not compatible with the standard mechanism of catalysis. However, since model B of 1.8 Å structure shows almost canonical hydrogen bonding, and we have unambigously demonstrated in the present study that SplA is catalytically active against peptide substrates, we conclude that the discussed phenomenon is an effect of crystal packing interactions. These, and all residues in the vicinity of 3.5 Å were omitted from the structure prior to simulated annealing and structure factor calculation. Additionally in (A), central dotted line mesh, F o -F c map at the level of 3.5σ . All water residues were omitted from the structure prior to simulated annealing and structure factor calculation.
Oxyanion hole
In the S1 family of serine proteases, the oxyanion hole stabilizes a tetrahedral transition-state intermediate of the carbonyl carbon atom of a scissile peptide bond by compensating the negative charge formed on the carbonyl oxygen. In contrast to what was previously reported for closely related enzymes, SplB protease [16] and ETs [44] , the conformation and Pro 151 -Gly 152 peptide bond in SplA supports a functional oxyanion hole similarly to the previously reported structure of V8 protease. In SplA, Pro 151 has average main chain angles of ϕ = − 44
• and ψ = 134 • ). In all of the mentioned enzymes, ϕ and ψ angles of following and preceding residues correspond with those found in type S1 family proteases. The described conformation of the Pro 151 -Gly 152 peptide bond in SplA is stabilized by hydrogen bonding of the carbonyl oxygen of Pro 151 with the amide of the Pro 119 -Lys 120 peptide bond. Since inhibitor treatment might have resulted in the observed placement of the Pro 151 -Gly 152 peptide bond, the 2.43 Å structure was carefully examined in the region in question. No evidence was found to support any alternative placement of the carbonyl oxygen of the described bond (for details see the Supplementary Online Data at http://www.BiochemJ.org/ bj/419/bj419ppppadd.htm). Therefore, apart from the described distortion of the catalytic triad histidine residue, the catalytic machinery of SplA corresponds to that found in type proteases of S1 family.
Specificity pockets
Substrate specificity of family S1 proteases is commonly determined by pronounced S1-P1 interactions. Accordingly, the S1 pocket of SplA is an easily distinguishable, spacious, bowlshaped cavity. It is delineated by loops I (Ala 149 -Ser 154 ; [39] , which is buried and only stabilizes the pocket. As such it closely resembles the S1 pocket of chymotrypsin and should easily accommodate bulky side chains of tyrosine and phenylalanine residues as determined in specificity assays. Homology modelling of substrate docking based on multiple available structures of synthetic peptide and canonical protein inhibitors in complex with S1 family proteases demonstrates that the side-chain oxygen of Asn 181 , which reaches the bottom of the S1 pocket in SplA, can possibly interact through a hydrogen bond with the tyrosine (P1) sidechain hydroxyl of the substrate (Figure 4) . The modelling also defines the S2 subsite. The main chain of the substrate adopts an extended β-sheet conformation and interacts via hydrogen bonds with the antiparallel β-strand of the enzyme formed by residues Leu 169 -Gly 172 . The branched side chain of leucine preferred in P2 docks into a shallow cleft formed by the side chains of two catalytic triad residues, His 39 and Asp 78 , and is further flanked by the side chains of Ala 171 and Tyr 170 . Contrary to the observed strong preference for aromatic side chains at the P3 substrate position, the S3 subsite is not clearly defined. Comparisons with structures of serine protease-inhibitor complexes and energy minimization of the SplA-YLY peptide complex give ambiguous results. It therefore seems likely that an induced fit mechanism may be involved.
Hydrogen bond network at the N-terminal
Precise N-terminal trimming is a prerequisite for the activity of type proteases of the chymotrypsin family. Similarly, we demonstrate in the present study that the addition of two amino acids at the N-terminus of SplA renders the protein inactive. A likely explanation is provided by the crystal structure. The Nterminal glutamic acid residue is firmly positioned on the surface of the molecule through a network of hydrogen bonds ( Figure 5 ). The main-chain amide and carbonyl oxygen of Glu 1 are hydrogen bonded respectively with the main chain carbonyl oxygen of Asp 146 and the main-chain amide of Tyr 148 as in a parallel β-sheet. The N-terminal amide is further hydrogen bonded to a side chain of Glu 179 while the Glu 1 backbone carbonyl forms an additional hydrogen bond with a water molecule, which is buried in the structure and further co-ordinated by the main-chain amide of Asn 3 . The side chain of Glu 1 forms a salt bridge with the side chain of Arg 112 and further hydrogen bonds with a water molecule and the sidechain of Thr 132 . Asn 3 begins a terminal strand of an antiparallel β-sheet. The tightly positioned residues of Glu 1 and Asn 3 hold in place the Lys 2 residue which by itself makes no pronounced contacts. Any N-terminal extension is not sterically compatible with the described Glu 1 positioning and thus requires breaking of the hydrogen bond network described. (A) Direct involvement of the N-terminal residue in P1 specificity pocket formation in V8 protease (1qy6; blue) and chymotrypsin (1afq; green). In SplA (2w7s; red) the N-terminal residue does not directly interact with the P1 specificity pocket. Shown are the N-terminal residue (mesh) and all residues in vicinity of 4 Å (stick model) overlaid over SplA structure (light brown, ribbon model; P1 specificity pocket forming residues, yellow stick model; catalytic triad residues, magenta stick model). (B) Hydrogen bond network at the N-terminus of SplA. All capable atoms of the N-terminal Glu 1 of mature SplA are involved in hydrogen bonding interactions. Shown is the F o -F c map at the level of 3.5σ . Glu 1 (model B, 2w7s) and all residues in the vicinity of 4 Å were omitted from the structure prior to simulated annealing and structure factor calculation. The interpretation of the shown map region is depicted as a stick model (CPK colouring). Hydrogen bonds are labelled as green dotted lines.
Putative in vivo SplA targets
A search of human and staphylococcal proteomes with the SplA consensus cleavage sequence suggests probable in vivo targets of the enzyme. Out of 90 identified human and 3 staphylococcal proteins (Supplementary Table S1 ), after analysis of tissue and cellular context together with the bacterial localization during commensal colonization as well as infection, two emerge as likely targets: mucin-16 (Q8WXI7) and OR (olfactory receptor) 5I1 (Q13606).
DISCUSSION
Similarly to SplB [15] , the proper N-terminal processing is necessary for the enzymatic activity of SplA. In a closely related V8 protease of S1B family, the N-terminal amino group released by cleavage of propeptide penetrates into the S1 pocket and it is directly responsible for charge neutralization of the P1 glutamic acid residue of a scissile peptide bond. Such a mechanism follows the classical pathway of S1A family serine protease zymogen activation, the most thoroughly studied examples of which include digestive tract proteases [45] . There, as in a multitude of other serine proteases, the new N-terminus liberated upon proteolytic processing of a precursor is directly involved in the formation of a functional primary specificity pocket ( Figure 5 ) [46] [47] [48] . Sequence alignment of SplA and V8 protease demonstrates that the polypeptide chain of mature SplA is four amino acids shorter at the N-terminus than that of V8 protease, making similar penetration in the former enzyme unlikely. Indeed, analysis of the crystal structure of SplA reveals a lack of direct involvement of the N-terminus in the formation of the S1 pocket. Nevertheless, the artificially, N-terminally elongated forms of Spl proteases, Gly-Ser-SplB [15] and Gly-Ser-SplA (the present study) show no activity in zymography.
The molecular mechanism by which the N-terminal extension controls activity of SplA protease is less obvious. The Nterminus is distant from either catalytic machinery or substrate recognition surface. Pronounced structural changes upon Nterminal elongation are unlikely since one-dimensional NMR spectra of SplA and GS-SplA are almost identical (results not shown). Therefore, most probably only distinct conformational changes and possibly small rearrangements in a network of hydrogen bonds regulate catalysis. Hydrogen bonding of Glu 1 amide to a side chain of Glu 179 , a residue close to the P1 specificity pocket, suggests influence on substrate recognition; however, certainly the mechanism is distinct to that observed in type proteases of family S1. A structure of N-terminally elongated SplA (e.g. GS-SplA) would probably help to clarify the mechanism, although it may involve a substantial dynamic constituent which might be hard to sensibly model based on static crystallographic data.
The inactivity of N-terminally elongated forms of Spl proteases seems not only a cloning artifact but rather a physiologically relevant phenomenon. Most proteolytic enzymes are synthesized as inactive zymogens as a protection against unwanted proteolysis. Only at target sites are the propeptides removed to release activity. Spl proteases lack propeptides of any kind and are secreted directly in an active form, being obviously harmless for the bacterium while outside the cell. The latter is similarly true for staphopains (S. arueus cysteine proteases) which are found in a mature, proteolytically active form in the culture medium. However, for efficient production of extracellular staphopains, specific intracellular inhibitors are necessary. It was demonstrated that knocking out these inhibitors decreases the viability of the bacterium. This demonstrates that a small amount of enzyme is misdirected into cytoplasm [9] . One may suspect that similarly a small amount of every secretory protein, and in particular of Spl proteases, remains inside the cell. This pool, however, contains a signal peptide at the N-terminus (which is cleaved off by a signal peptidase only upon secretion) and thus remains catalytically inactive. As such the signal peptide acts both as a secretion signal and a propeptide controlling the enzyme activity, which probably explains the lack of demonstrated intracellular serine protease inhibitors in staphylococci.
The high substrate specificity of SplA protease, defined by three consecutive residues of a substrate, is uncommon among S1 family proteases. Homology modelling of substrate binding clearly defines the structural determinants of P1 and P2 preference. The strong propensity for aromatic P3 substrate residue could not have been satisfactorily explained by modelling suggesting an induced fit mechanism might be involved. A crystal structure of SplA complexed with a substrate analogue is therefore desirable to clarify this issue.
Parallel to the classical subsite-based substrate recognition, oxyanion hole distortion was suggested to take part in specificity determination of SplB [16] . In SplA, the arrangement of the Ser 154 and Gly 152 amides is similar to that observed in type serine proteases and different from that in SplB, therefore a similar mechanism is not involved here.
Many proteases produced by pathogenic bacteria play crucial role in virulence. The broad substrate specificity enzymes are generally involved in unspecific processes such as acquisition of nutrients and dissemination (both associated with tissue damage). In turn, highly specific proteases often act as dedicated toxins exerting activity on a narrow subset of proteins or even on a single substrate. The narrow specificity of SplA suggests a similar role. Deciphering the role of specific proteases in virulence is most interesting, but also a highly challenging undertaking. A search for physiological substrates of ETs took nearly 30 years to achieve [49] . Considering pronounced similarity of Spl proteases to staphylococcal virulence factors, location of the spl operon within the pathogenicity island [14] , expression during staphylococcal endocarditis [11] and highly limited substrate specificity, it is tempting to speculate that Spl proteases represent yet another group of S. aureus-specific toxins. Analysis of the human proteome with the deduced consensus sequence recognized by SplA points to two fascinating putative targets. OR 5I1, a member of a large family of transmembrane sensory proteins, is clearly found in the primary colonization site of S. aureus. One may speculate that its cleavage may facilitate the colonization and/or persistence of S. aureus in the nares, or facilitate dissemination from this primary niche into the human body by yet unknown mechanisms. What is certain is that consensus cleavage site of SplB protease was found in other members of the OR family [16] . Another identified protein, mucin-16 (MUC16), possesses two putative cleavage sites for SplA. Mucin-16 is a heavily O-glycosylated transmembrane protein, which is expressed by the ocular surface epithelia in which it helps to provide a disadhesive protection barrier [50] . S. aureus is a leading cause of bacterial keratitis in adults that can result in irreversible corneal scarring and loss of visual acuity. To date mainly α-and β-toxin of S. aureus were convincingly demonstrated as virulence factors in corneal disease. In the context of staphylococcal corneal infection, cleavage of MUC16 by SplA is worth detailed investigation. Although the above findings on the possible physiological role of SplA protease are highly speculative, they open an exciting avenue for future research on related aspects of staphylococcal physiology.
In previously reported structures of enzymes closely related to SplA, the SplB protease [1] and ETs [2] , the conformation of a peptide bond between residues n-2 and n-3 relative to the catalytic triad Ser(n) does not support a functional oxyanion hole. Although the deviation from the canonical structure is small and involves only a 180
• flip of a single peptide bond, it is meaningful since the feature is crucial to the catalytic mechanism of serine proteases of family S1. Therefore the disposition of the peptide bond in question was investigated in detail in the structure of SplA as reported below.
The Pro 151 -Gly 152 peptide bond conformation in the structure of SplA supports a canonical conformation of the oxyanion hole which is clearly shown by experimental results in both the 2w7u and 2w7s structures. SA (simulated annealing) omit maps of the discussed region ( Figures S2 and S3 ) confirm the correct placement of the discussed peptide bond in both the 2.43 Å and the 1.8 Å models.
The interpretation of the map shown in Figure S3 is unequivocal; however, the map for the 2. To conclude, the experimental results collected in the present paper on both 2.43 Å and 1.8 Å diffracting crystals unambigously demonstrate the canonical placement of the peptide bond between residues n-3 and n-2 [relative to catalytic triad Ser(n)], supporting the formation of a functional oxyanion hole. The disposition of the peptide bond in question is similar to those found in type proteases of S1 family and does not corresopnd to that found in closely related enzymes, SplB and ETs. 
